Atlas Trials

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Clinical trial NCT00867126 · TERMINATED

Trial details

NCT number
NCT00867126
Sponsor
University of Texas Southwestern Medical Center
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2009-03-02
Primary completion
2012-02-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.